Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Caribou Biosciences Inc’s current trading price is -37.32% away from its 52-week high, while its distance from the 52-week low is 184.85%. The stock’s price range during this period has varied between $0.66 and $3.00. The company, active in the Healthcare sector, saw a trading volume of around 1.43 million for the day, considerably lower average daily volume of 1.58 million observed over the last three months.
Caribou Biosciences Inc (CRBU) has a current stock price of $1.88. During the previous trading session, the stock witnessed a notable rise, reaching a high of $32.0 after opening at $1.88. The stock’s low for the day was $1.0, and it eventually closed at $2.04.
Caribou Biosciences Inc’s stock has seen a smooth market performance.
How Financial Performance Impacts Market Capitalization
Caribou Biosciences Inc (CRBU) has experienced a quarterly rise of 149.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 174.85M and boasts a workforce of 147 employees.
Decoding Analysts’ Ratings for Caribou Biosciences Inc
As of right now, 5 analysts are rating Caribou Biosciences Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.22, with a change in price of +0.89. Similarly, Caribou Biosciences Inc recorded 1,402,448 in trading volume during the last 100 days, posting a change of +90.77%.
How CRBU’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRBU Stock Stochastic Average
As of today, the raw stochastic average of Caribou Biosciences Inc over the last 50 days is at 54.19%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 26.07%. Further, the company’s Stochastic %K and %D values for the last 20 days were 40.74% and 46.48%, respectively.
CRBU Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -11.74% this year. Over the last six months, there has been a weaker performance of 34.29%. The price of CRBU fallen by 17.50% during the last 30 days period. For the last 5-days stocks have slided -8.29%.
